Capitol Hill BSE
This article was originally published in The Tan Sheet
Executive Summary
DSHEA inadequately protects public from mad cow disease, Public Citizen Health Research Group Deputy Director Peter Lurie, MD, asserts at Senate Commerce, Science & Transportation/Consumer Affairs Subcommittee hearing on bovine spongiform encephalopathy April 4. Due to absence of mandatory premarket review under DSHEA, "an unscrupulous manufacturer could literally take a British cow brain, crush it, dry it out, formulate it into a dietary supplement and export it to the U.S.," he says in written testimony. Lurie also referred to Walter Reed Army Medical Center researcher Scott Norton's letter in July 27 New England Journal of Medicine noting numerous supplements contain raw animal parts and therefore are "susceptible to contamination with the agents of" BSE (1"The Tan Sheet" Aug. 7, 2000, p. 17)
You may also be interested in...
BioProgress Gelatin-Free Capsules Address Vegetarian, Ethical Concerns
BioProgress Technology International's XGel Film System, the first one-piece soft capsule technology containing a cellulose base instead of gelatin, has been licensed by Peter Black Healthcare, the leading supplier of private label vitamins, minerals and herbal supplements in the U.K.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands